Citation: Am. Ouagazzal et al., Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?, PSYCHOPHAR, 156(2-3), 2001, pp. 273-283
Authors:
Andreatini, R
Blanchard, C
Blanchard, R
Brandao, ML
Carobrez, AP
Griebel, G
Guimaraes, FS
Handley, SL
Jenck, F
Leite, JR
Rodgers, J
Schenberg, LC
Da Cunha, C
Graeff, FG
Citation: R. Andreatini et al., The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis, BRAZ J MED, 34(2), 2001, pp. 145-154
Authors:
Higgins, GA
Grottick, AJ
Ballard, TM
Richards, JG
Messer, J
Takeshima, H
Pauly-Evers, M
Jenck, F
Adam, G
Wichmann, J
Citation: Ga. Higgins et al., Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function, NEUROPHARM, 41(1), 2001, pp. 97-107
Authors:
Dautzenberg, FM
Wichmann, J
Higelin, J
Py-Lang, G
Kratzeisen, C
Malherbe, P
Kilpatrick, GJ
Jenck, F
Citation: Fm. Dautzenberg et al., Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: Rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo, J PHARM EXP, 298(2), 2001, pp. 812-819
Authors:
Rover, S
Wichmann, J
Jenck, F
Adam, G
Cesura, AM
Citation: S. Rover et al., ORL1 receptor ligands: Structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones, BIOORG MED, 10(8), 2000, pp. 831-834
Authors:
Le Pen, G
Grottick, AJ
Higgins, GA
Martin, JR
Jenck, F
Moreau, JL
Citation: G. Le Pen et al., Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia, BEHAV PHARM, 11(3-4), 2000, pp. 257-268
Authors:
Kew, JNC
Koester, A
Moreau, JL
Jenck, F
Ouagazzal, AM
Mutel, V
Richards, JG
Trube, G
Fischer, G
Montkowski, A
Hundt, W
Reinscheid, RK
Pauly-Evers, M
Kemp, JA
Bluethmann, H
Citation: Jnc. Kew et al., Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site, J NEUROSC, 20(11), 2000, pp. 4037-4049
Authors:
Wichmann, J
Adam, G
Rover, S
Hennig, M
Scalone, M
Cesura, AM
Dautzenberg, FM
Jenck, F
Citation: J. Wichmann et al., Synthesis of (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties, EUR J MED C, 35(9), 2000, pp. 839-851
Authors:
Jenck, F
Wichmann, J
Dautzenberg, FM
Moreau, JL
Ouagazzal, AM
Martin, JR
Lundstrom, K
Cesura, AM
Poli, SM
Roever, S
Kolczewski, S
Adam, G
Kilpatrick, G
Citation: F. Jenck et al., A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat, P NAS US, 97(9), 2000, pp. 4938-4943
Citation: F. Jenck et al., The 5-HT1A receptor agonist flesinoxan increases aversion in a model of panic-like anxiety in rats, J PSYCHOPH, 13(2), 1999, pp. 166-170
Authors:
Koster, A
Montkowski, A
Schulz, S
Stube, EM
Knaudt, K
Jenck, F
Moreau, JL
Nothacker, HP
Civelli, O
Reinscheid, RK
Citation: A. Koster et al., Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice, P NAS US, 96(18), 1999, pp. 10444-10449